University of California Irvine Medical Center
Published: 3 Dec 2008
Views: 14969
Prof. Bradley Monk
Promising new treatment option for women with recurrent ovarian cancer.
- Categories:
- Ovary & gynaecology
Related Videos
OncoAlert and ecancer - ESMO 2021 Day 3
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
19 Sep 2021
Immunotherapy prolongs survival in recurrent, persistent or metastatic cervical ...
Prof Bradley Monk - University of Arizona College of Medicine, Phoenix, USA
18 Sep 2021
ESMO President: What to watch for at ESMO 2021
Prof Solange Peters - ESMO President
17 Sep 2021
Multidisciplinary management of ovarian germ cell tumours - a single institution...
Dr Sandip Ganguly - Tata Medical Center, Kolkata, India
14 Sep 2021
OncoAlert and ecancer weekly round up for August 23rd - August 29th, 2021
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
31 Aug 2021
OncoAlert and ecancer ASCO roundup - Day 4 and 5
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
16 Jun 2021
Adjuvant chemo following chemoradiation as treatment for locally advanced cervic...
Dr Linda Mileshkin - Peter MacCallum Cancer Center, Melbourne, Australia
10 Jun 2021
Incidence and trends of HPV-related cancers in the United States
Dr John Chan - UCSF Helen Diller Family Comprehensive Cancer Center, San Francis...
4 Jun 2021
Special Issue: Women’s cancer care in fragile, conflict-impacted ecosystems
Special issue authors and funders
16 May 2021
